![](/img/cover-not-exists.png)
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
Quintela-Fandino, Miguel, Morales, Serafín, Cortés-Salgado, Alfonso, Manso, Luis, Apala, Juan V., Muñoz, Manuel, Gasol Cudos, Ariadna, Salla Fortuny, Joel, Gion, María, Lopez-Alonso, Antonio, Cortés,Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-2023
Date:
October, 2019
File:
PDF, 1003 KB
2019